DK327288A - PHARMACEUTICALS CONTAINING PROGESTERONE SYNTHESIS SYMPTOMS OF TRILOSTAN OR EPOSTAN AND ANTIGESTENES - Google Patents

PHARMACEUTICALS CONTAINING PROGESTERONE SYNTHESIS SYMPTOMS OF TRILOSTAN OR EPOSTAN AND ANTIGESTENES

Info

Publication number
DK327288A
DK327288A DK327288A DK327288A DK327288A DK 327288 A DK327288 A DK 327288A DK 327288 A DK327288 A DK 327288A DK 327288 A DK327288 A DK 327288A DK 327288 A DK327288 A DK 327288A
Authority
DK
Denmark
Prior art keywords
epostan
antigestenes
trilostan
symptoms
progesterone synthesis
Prior art date
Application number
DK327288A
Other languages
Danish (da)
Other versions
DK327288D0 (en
Inventor
Walter Elger
Sybille Beier
Beate Kosub
Marianne Faehnrich
Krzysztof Chwalisz
Syed Hamiduddin Hasan
Gordon Oliver Potts
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK327288D0 publication Critical patent/DK327288D0/en
Publication of DK327288A publication Critical patent/DK327288A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The medicine contains a progesterone synthesis inhibitor (ProH) of the trilostane or epostane type and an antigestagen (AG) and is used for inducing labour at term in humans and animals and for terminating normal or pathological pregnancy. The combination according to the invention is also suitable for treating hormone-dependent tumours, endometriosis and dysmenorrhoea.
DK327288A 1987-06-16 1988-06-15 PHARMACEUTICALS CONTAINING PROGESTERONE SYNTHESIS SYMPTOMS OF TRILOSTAN OR EPOSTAN AND ANTIGESTENES DK327288A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873720420 DE3720420A1 (en) 1987-06-16 1987-06-16 PROGESTERONE SYNTHESIS INHIBITOR AND ANTI-STAGE TO BEGINNING BIRTH OR FOR PREGNANCY

Publications (2)

Publication Number Publication Date
DK327288D0 DK327288D0 (en) 1988-06-15
DK327288A true DK327288A (en) 1988-12-17

Family

ID=6329981

Family Applications (1)

Application Number Title Priority Date Filing Date
DK327288A DK327288A (en) 1987-06-16 1988-06-15 PHARMACEUTICALS CONTAINING PROGESTERONE SYNTHESIS SYMPTOMS OF TRILOSTAN OR EPOSTAN AND ANTIGESTENES

Country Status (12)

Country Link
EP (1) EP0296097B1 (en)
JP (1) JP2716461B2 (en)
AT (1) ATE94391T1 (en)
AU (1) AU611160B2 (en)
CA (1) CA1318251C (en)
DE (2) DE3720420A1 (en)
DK (1) DK327288A (en)
ES (1) ES2059556T3 (en)
IE (1) IE63453B1 (en)
IL (1) IL86731A (en)
PH (1) PH25728A (en)
ZA (1) ZA884315B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2145539C (en) * 1992-09-25 2003-07-29 Clive Barnes Preventing contaminant build-up in beer lines
GB2345851B (en) * 2000-01-18 2004-05-26 Gavin Paul Vinson A combination of trilostane or keto-trilostane and an anti-oestrogen for the treatment of an oestrogen-dependent cancer or tumour

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4062954A (en) * 1976-12-27 1977-12-13 Sterling Drug Inc. Process for using a steroid compound
IL68222A (en) * 1983-03-24 1987-02-27 Yeda Res & Dev Contraceptive compositions comprising a progesterone antagonist and a blocker of progesterone activity

Also Published As

Publication number Publication date
EP0296097A3 (en) 1990-04-04
IL86731A0 (en) 1988-11-30
IE881804L (en) 1988-12-16
EP0296097A2 (en) 1988-12-21
IL86731A (en) 1992-11-15
IE63453B1 (en) 1995-04-19
DE3884067D1 (en) 1993-10-21
ATE94391T1 (en) 1993-10-15
DK327288D0 (en) 1988-06-15
PH25728A (en) 1991-10-18
AU1775088A (en) 1988-12-22
JP2716461B2 (en) 1998-02-18
ES2059556T3 (en) 1994-11-16
ZA884315B (en) 1989-06-28
DE3720420A1 (en) 1988-12-29
AU611160B2 (en) 1991-06-06
EP0296097B1 (en) 1993-09-15
JPS63316725A (en) 1988-12-26
CA1318251C (en) 1993-05-25

Similar Documents

Publication Publication Date Title
NO874712D0 (en) PROCEDURE AND DEVICE FOR DETECTION OF CORROSION OR SIMILAR.
DE3780924D1 (en) DEVICE FOR THE EXAMINATION OF THERMAL STRESSES.
NO873753L (en) PERIODIC BIOLOGICAL AIR TREATMENT PROCESS AND SYSTEM FOR THIS.
DK464578A (en) PROCEDURE FOR THE PREPARATION OF 3-SUBSTITUTED AND 6-SUBSTITUTED 7-OXO-1-AZABICYCLO (3,2,0) HEPT-2-EN-2-CARXYLIC ACIDS OR AMIES THEREOF
NO902664D0 (en) PROCEDURE AND DEVICE FOR CONTROL OR CONTROL OF THE HEAT LEVEL TO A POWDER-SOLID SUBSTANCE.
NO873563D0 (en) PROCEDURE AND DEVICE FOR HEATING OF GAS CREATED BY COOLING WATER.
DE58906330D1 (en) Device for ventilation of protective suits.
FR2324010A1 (en) METHOD AND DEVICE FOR ELIMINATION OF PARASITES COMBINED WITH AN INPUT SIGNAL.
FI884319A0 (en) FOERFARANDE FOER ATT SPJAELKA SVAORSPJAELKBARA AROMATER I KONTAMINERADE BOTTEN ELLER DEPONERINGSAEMNEN MED MIKRO-ORGANISMER.
DK327288A (en) PHARMACEUTICALS CONTAINING PROGESTERONE SYNTHESIS SYMPTOMS OF TRILOSTAN OR EPOSTAN AND ANTIGESTENES
NO883743D0 (en) PROCEDURE AND DEVICE FOR AA GIVING PERSONAL AIR CONDITION ("AIR CONDITION").
FI861530A (en) RELEASE OF GIPS ELLER KRITA I VATTEN.
ES510546A0 (en) "PROCEDURE FOR PREPARING DERIVATIVES OF N- (N-METHYL-RN (N-AMINOSULFENYL DISUBSTITUTED) CARBAMOIL) OXI) S-METHYL THIOACETAMIDATE".
DE3789032D1 (en) Mechanism for setting an output link.
NO882066D0 (en) PROCEDURE AND DEVICE FOR AA MAJOR OR HORIZONTALLY DIRECTED BORING.
NO150511C (en) PROCEDURE FOR THE PREPARATION OF MONOCLORACETYL-CHLORIDE FROM TRICLORETHYL AND / OR 1,1,1,2-TETRACHLORANEETHAN
JPS5248944A (en) Information processing system control system
JPS5278336A (en) On-line processing system
FI872681A0 (en) CHEMIST SJAELVKOPIERANDE ELLER ENSAMKOPIERANDE PAPPER.
JPS5416955A (en) Computer system for process control
JPS5277555A (en) Cash register having card processing function
JPS5419622A (en) Control system for response confirmation
DE3788424T2 (en) TEST PROCEDURE OF THE HUMAN B-LYMPHOTROPIC VIRUS (HBLV).
JPS5334493A (en) Control system for electroluminescence display panel
IT7924543A0 (en) UNIVERSAL CAGES FOR NUTS OR SCREWS.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment